AC
NVAX icon

Allstate Corporation’s Novavax NVAX Stock Holding History

Allstate Corporation’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$152K Buy
16,154
+832
+5% +$7.46K ﹤0.01% 1313
2026
Q1 		$125K Buy
+15,322
New +$139K ﹤0.01% 1119
2022
Q1 		– Sell
-6,984
Closed -$999K – 706
2021
Q4 		$999K Buy
6,984
+5,352
+328% +$920K 0.02% 539
2021
Q3 		$338K Sell
1,632
-8
-0.5% -$1.76K 0.01% 602
2021
Q2 		$348K Buy
+1,640
New +$300K 0.01% 620

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $526M AUM 46.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return

Allstate Corporation's NVAX Position: Q2 2026 in Review

Allstate Corporation increased its Novavax (NVAX) stake by 5.4% in Q2 2026, buying an estimated $7.46K and bringing the position to 16,154 shares worth $152K. The position accounts for ﹤0.01% of the portfolio, ranked #1313.

Allstate Corporation first reported a position in NVAX in Q2 2021 and has held it in 5 quarters since. The position peaked at $999K in Q4 2021. 266 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

  • Allstate Corporation held 16,154 shares of Novavax worth $152K as of Q2 2026.
  • Allstate Corporation bought 832 Novavax shares in Q2 2026, an estimated $7.46K.
  • Novavax made up ﹤0.01% of Allstate Corporation's portfolio in Q2 2026, its #1313 holding.
  • Allstate Corporation first reported a position in Novavax in Q2 2021 and has held it in 5 quarters since.
  • Allstate Corporation's Novavax position peaked at $999K in Q4 2021.
  • 266 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on Allstate Corporation's 13F filing for Q2 2026, filed 13 Aug 2026.